Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2300410	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31		GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHZ2300409	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31		GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHZ2300408	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2023-10-31		GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHZ1900158	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production	Certificate Issued	2019-11-25	view
JYHZ1900157	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2019-07-01	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production	Certificate Issued	2019-11-25	view
JYHZ1800391	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	License Renew	2018-11-30	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production	Certificate Issued	2019-05-24	view
JYHB2200293	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-06-14		Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHB2200292	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-06-14		Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHB2101629	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-12-30		Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHB2101628	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-01-05		Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHB2101627	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2022-01-05		Laboratoire Glaxosmithkline;Glaxo Wellcome Production			view
JYHB2101420	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-09-16		Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production			view
JYHB2101419	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-09-16		Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production			view
JYHB2100101	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2021-01-29	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production	In Review	2021-01-28	view
JYHB2001446	沙美特罗替卡松吸入气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2020-08-21	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production	Filed	2020-09-01	view
JYHB1601402	沙美特罗替卡松气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2016-11-16	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production	Certificate Issued	2017-06-06	view
JYHB1601401	沙美特罗替卡松气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2016-11-16	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production	Certificate Issued	2017-06-06	view
JYHB1601400	沙美特罗替卡松气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2016-11-16	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production	Certificate Issued	2017-06-06	view
JYHB1600992	沙美特罗替卡松气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2016-08-11	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production	Certificate Issued	2019-05-24	view
JYHB1401314	沙美特罗替卡松气雾剂	fluticasone propionate;salmeterol xinafoate	Aerosol	Chemical Drugs	Supplementary Application	2014-10-14	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production	Certificate Issued	2015-05-29	view